Ticker League

Operating Cash Flow for IDEXX Laboratories (IDXX)

As of · Reported

Metric

Latest period

$266.25M

YoY change

+26.8%

5Y CAGR

+12.7%

Peak year (2025)

$1.18B

Operating Cash Flow history chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: $1.18B

Operating Cash Flow growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: +26.8%

Operating Cash Flow history table for IDEXX Laboratories (IDXX) from 1991 to 2025

  • 2025$1.18B+26.8%
  • 2024$929.00M+2.5%
  • 2023$906.51M+66.9%
  • 2022$542.98M-28.1%
  • 2021$755.55M+16.6%
  • 2020$648.06M+41.1%
  • 2019$459.16M+14.8%
  • 2018$400.08M+7.2%
  • 2017$373.28M+11.6%
  • 2016$334.57M+54.6%
  • 2015$216.36M-8.3%
  • 2014$235.85M-4.1%
  • 2013$246.00M+6.8%
  • 2012$230.28M+4.3%
  • 2011$220.70M+23.4%
  • 2010$178.83M+2.9%
  • 2009$173.72M+21.2%
  • 2008$143.34M+6.1%
  • 2007$135.12M+23.0%
  • 2006$109.83M-5.8%
  • 2005$116.55M+22.2%
  • 2004$95.38M-18.6%
  • 2003$117.16M+13.5%
  • 2002$103.25M+122.7%
  • 2001$46.36M+64.2%
  • 2000$28.24M-46.3%
  • 1999$52.60M+14.1%
  • 1998$46.10M+241.5%
  • 1997$13.50M+68.8%
  • 1996$8.00M+17.6%
  • 1995$6.80M-54.1%
  • 1994$14.80M+100.0%
  • 1993$7.40M-7500.0%
  • 1992−$100.00K-102.6%
  • 1991$3.80M—

Operating Cash Flow values are taken from IDEXX Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at IDEXX Laboratories (IDXX)

Operating Cash Flow for IDEXX Laboratories (IDXX): headline value $266.25M · YoY +26.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual operating cash flow for IDEXX Laboratories (IDXX) came in at $1.18B – grew 26.8% year-over-year.

IDEXX Laboratories operating cash flow has grown for 3 consecutive years, with a +12.7% compound annual growth rate over 2020–2025 (5 years).

The record annual operating cash flow stands at $1.18B, reached in 2025; the historical low of −$100.00K was recorded in 1992.

IDEXX Laboratories Operating Cash Flow by Year

IDEXX Laboratories Operating Cash Flow 2025: $1.18B

IDEXX Laboratories posted operating cash flow of $1.18B in 2025, grew 26.8% from 2024. This figure represents the highest annual value in the available history.

IDEXX Laboratories Operating Cash Flow 2024: $929.00M

In 2024, IDEXX Laboratories reported operating cash flow of $929.00M, edged up 2.5% from 2023.

IDEXX Laboratories Operating Cash Flow 2023: $906.51M

IDEXX Laboratories operating cash flow in 2023 was $906.51M, surged 66.9% from 2022.

IDEXX Laboratories Operating Cash Flow 2022: $542.98M

2022's operating cash flow for IDEXX Laboratories came in at $542.98M, declined 28.1% below 2021.

IDEXX Laboratories Operating Cash Flow 2021: $755.55M

IDEXX Laboratories operating cash flow in 2021 was $755.55M.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers by Operating Cash Flow

Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest operating cash flow

Frequently asked questions

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends paid by this company.